The author Sangita Baxi and a Pfizer representative contacted the editorial office to raise that there are image duplications in this article. Pfizer has undertaken a review and determined that there are duplications in Fig 1 and Fig 2 of the article and that part of the experiments cannot be verified.
In light of the concerns identified, the authors and the PLOS ONE Editors retract this article. We did not receive any response or comment from Min-Jean Yin, Wei Tan, or Tod Smeal.
Citation: The PLOS ONE Editors (2017) Retraction: Targeting 3-Phosphoinoside-Dependent Kinase-1 to Inhibit Insulin-Like Growth Factor-I Induced AKT and p70 S6 Kinase Activation in Breast Cancer Cells. PLoS ONE 12(4): e0175772. https://doi.org/10.1371/journal.pone.0175772
Published: April 10, 2017
Copyright: © 2017 The PLOS ONE Editors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.